Literature DB >> 6420790

Localization of the structural gene for human apolipoprotein A-I on the long arm of human chromosome 11.

P Cheung, F T Kao, M L Law, C Jones, T T Puck, L Chan.   

Abstract

Apolipoprotein A-I (apo A-I), the major apolipoprotein in human high density lipoproteins, is involved in the disease atherosclerosis. Cloned apo A-I cDNA (pA1-3) was used as a probe in chromosome mapping studies to detect the human apo A-I structural gene sequence in human-Chinese hamster cell hybrids. Southern blot analysis of 13 hybrids localized the gene to human chromosome 11. Confirmation of the chromosomal assignment was obtained by analysis of a hybrid (J1) containing a single human chromosome, no. 11. Regional mapping was achieved by using deletion subclones of J1 that localized the human apo A-I structural gene to the region 11q13 leads to qter. Since the human apolipoprotein C-III (apo C-III) structural gene is closely linked to apo A-I, it can be assigned to the same region on the long arm of chromosome 11. By extension of methods previously described, it now appears possible to carry out fine-structure analysis of this and related gene regions on chromosome 11 and to study the biochemical concomitants of these genes and of genes on other chromosomes for analysis of their role in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420790      PMCID: PMC344707          DOI: 10.1073/pnas.81.2.508

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Phosphorylation changes induced by cAMP derivatives in the CHO cell and selected mutants.

Authors:  E G Gabrielson; C Scoggin; T T Puck
Journal:  Exp Cell Res       Date:  1982-11       Impact factor: 3.905

3.  Genetic fine-structure mapping in human chromosome 11 by use of repetitive DNA sequences.

Authors:  J F Gusella; C Jones; F T Kao; D Housman; T T Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

4.  Assignment of the structural gene coding for albumin to human chromosome 4.

Authors:  F T Kao; J W Hawkins; M L Law; A Dugaiczyk
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

5.  Assignment of the alpha 1-antitrypsin gene and a sequence-related gene to human chromosome 14 by molecular hybridization.

Authors:  E C Lai; F T Kao; M L Law; S L Woo
Journal:  Am J Hum Genet       Date:  1983-05       Impact factor: 11.025

6.  Apolipoprotein AIMarburg: studies on two kindreds with a mutant of human apolipoprotein AI.

Authors:  G Utermann; A Steinmetz; R Paetzold; J Wilk; G Feussner; H Kaffarnik; C Mueller-Eckhardt; D Seidel; K H Vogelberg; F Zimmer
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

7.  Gene structure of human apolipoprotein A1.

Authors:  C C Shoulders; A R Kornblihtt; B S Munro; F E Baralle
Journal:  Nucleic Acids Res       Date:  1983-05-11       Impact factor: 16.971

8.  Genetic control of lipid transport in mice. II. Genes controlling structure of high density lipoproteins.

Authors:  A J Lusis; B A Taylor; R W Wangenstein; R C LeBoeuf
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

9.  Nucleotide sequence of cloned cDNA of human apolipoprotein A-I.

Authors:  P Cheung; L Chan
Journal:  Nucleic Acids Res       Date:  1983-06-11       Impact factor: 16.971

10.  Resistance of Chinese hamster ovary cell chromatin to endonuclease digestion. I. Reversal by cAMP.

Authors:  S Schonberg; D Patterson; T T Puck
Journal:  Exp Cell Res       Date:  1983-04-15       Impact factor: 3.905

View more
  33 in total

1.  Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment.

Authors:  France Gagnon; Gail P Jarvik; Arno G Motulsky; Samir S Deeb; John D Brunzell; Ellen M Wijsman
Journal:  Hum Genet       Date:  2003-08-29       Impact factor: 4.132

2.  Structure, evolution, and polymorphisms of the human apolipoprotein A4 gene (APOA4).

Authors:  S K Karathanasis; P Oettgen; I A Haddad; S E Antonarakis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Deletion polymorphism 5' to the human apolipoprotein AI (apo AI) gene.

Authors:  P M Frossard; R T Coleman; A A Protter; J J Seilhamer; H Funke; G Assmann
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

Review 4.  Mouse chromosome 9.

Authors:  D M Kingsley
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

5.  Tetranucleotide repeat polymorphism in the apolipoprotein C-III gene.

Authors:  G Zuliani; H H Hobbs
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

6.  Assignment of the apolipoprotein A-I gene to 11q23 based on RFLP in a case with a partial deletion of chromosome 11, del(11)(q23.3----qter).

Authors:  T Arinami; T Hirano; K Kobayashi; Y Yamanouchi; H Hamaguchi
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

7.  DNA polymorphic sites in the human ApoAI-CIII-AIV cluster: Taq I and Ava I.

Authors:  T Cohen; S K Karathanasis; H H Kazazian; S E Antonarakis
Journal:  Nucleic Acids Res       Date:  1986-02-25       Impact factor: 16.971

8.  PvuII polymorphic site upstream to the human ApoCIII gene.

Authors:  P Oettgen; S E Antonarakis; S K Karathanasis
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

9.  A frequent polymorphism of the complement component C4 gene.

Authors:  R Goldstein; J Gruhn; F C Arnett; M Duvic
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

10.  An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population.

Authors:  Q Zeng; M Dammerman; Y Takada; A Matsunaga; J L Breslow; J Sasaki
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.